Description
Ecromeximab (KM 871; KW 2871) is a mouse-derived IgG-κ chimeric antibody targeting ganglioside GD3. Ecromeximab is expressed by YB2/0 rat hybridoma cells.
Cat.No
A137
Name
Ecromeximab
Chemical Properties
CAS
292819-64-8
Synonyms
Immunoglobulin G1,anti-(GD3 ganglioside) (human-mouse monoclonal KM871 g1-chain), disulfide withhuman-mouse monoclonal KM871 k-chain, dimer;Immunoglobulin G1,anti-(GD3 ganglioside) (human-mouse monoclonal KM871 g1-chain), disulfide withhuman-mouse monoclonal KM871 ;Ecromeximab;KM 871;KW 2871;Km871;Kw 2871;Kw-2871;ECROMEXIMABUM;Research Grade Ecromeximab (DGK11301)
pH value
Corresponds to reference standard: PASS
Non-reduced CE-SDS
>95%
SEC-HPLC
>95%
Isoelectric Point
Corresponds to reference standard
Bacterial Endotoxins Test
Residual Proteins of Host Cell
Exogenous Residual DNA
Residual protein A
Biological Activity
Osmolality
Corresponds to reference standard: PASS
Peptide mapping
Corresponds to reference standard: PASS
N-terminal sequence
Corresponds to reference standard: PASS
References
Return Policy
If you are in any way unsatisfied with your purchase, you may return any item(s) within 365 days of its original purchase date.
Please provide your Order Number in the email. We strive to reply to all email inquiries within one business day.
Tel: +86-21-58447131Fax: +86-21-61642470Email:
Website:
.png)